Covaxin is effective against UK variant of coronavirus: ICMR study
PTI, Jan 28, 2021, 4:17 PM IST
Covaxin is effective against the new variant of COVID-19 that was traced in the UK, an ICMR study has said. “Covaxin, developed by Bharat Biotech with ICMR, has equivalent immunogenicity against the UK-variant and circulating strains of SARS-COV-2 in India,” tweeted ICMR.
“It’s reassuring the vaccine can work against the new UK variant,” said ICMR Director General Dr Balram Bhargava.
As reported by Indian Express, While the data collected from 38 people looks promising, there is no clarity on the vaccine’s efficacy yet, as it is being administered to priority groups in “clinical trial” mode. Greater clarity is expected to emerge later this year, when Bharat Biotech will have enough information to say how effective the vaccine is in preventing those inoculated from showing serious symptoms, even if they do get infected.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Surgical options for Parkinson’s disease
Breast cancer to cause a million deaths a year by 2040: Lancet commission
Will to resist temptations, achieve goals more trustworthy than using apps, study finds
Govt directs e-commerce firms to remove drinks, beverages from ‘health drinks’ category
Experiencing abuse, neglect as child linked to lifelong ill-health: Study
MUST WATCH
Latest Additions
India’s boundaries are completely secure: Rajnath Singh
Complaint filed against Flipkart, BigBasket for allegedly making employee work on election day
DKShi ‘kidnapped’ 9-year-old girl for property: HDD
Woman can’t be held accountable for abetting suicide of lover due to ‘love failure’: Delhi HC
I don’t believe in star power: Vidhu Vinod Chopra on why content matters more to him